| Disease‐modifying therapies and coronavirus disease 2019 severity in multiple sclerosis MP Sormani, N De Rossi, I Schiavetti, L Carmisciano, C Cordioli, L Moiola, ... Annals of neurology 89 (4), 780-789, 2021 | 89 | 2021 |
| Brain intra-and extracellular sodium concentration in multiple sclerosis: a 7 T MRI study M Petracca, RO Vancea, L Fleysher, LE Jonkman, N Oesingmann, ... Brain 139 (3), 795-806, 2016 | 64 | 2016 |
| Tract-specific white matter correlates of fatigue and cognitive impairment in benign multiple sclerosis M Bester, M Lazar, M Petracca, JS Babb, J Herbert, RI Grossman, ... Journal of the neurological sciences 330 (1-2), 61-66, 2013 | 62 | 2013 |
| Cerebellar lobule atrophy and disability in progressive MS S Cocozza, M Petracca, E Mormina, K Buyukturkoglu, K Podranski, ... Journal of Neurology, Neurosurgery & Psychiatry 88 (12), 1065-1072, 2017 | 38 | 2017 |
| Cerebellum and neurodegenerative diseases: beyond conventional magnetic resonance imaging E Mormina, M Petracca, G Bommarito, N Piaggio, S Cocozza, M Inglese World journal of radiology 9 (10), 371, 2017 | 33 | 2017 |
| Retinal degeneration in primary-progressive multiple sclerosis: a role for cortical lesions? M Petracca, C Cordano, M Cellerino, J Button, S Krieger, R Vancea, ... Multiple Sclerosis Journal 23 (1), 43-50, 2017 | 31 | 2017 |
| Sodium MRI of multiple sclerosis M Petracca, L Fleysher, N Oesingmann, M Inglese NMR in Biomedicine 29 (2), 153-161, 2016 | 30 | 2016 |
| Association of deep gray matter damage with cortical and spinal cord degeneration in primary progressive multiple sclerosis S Ruggieri, M Petracca, A Miller, S Krieger, R Ghassemi, Y Bencosme, ... JAMA neurology 72 (12), 1466-1474, 2015 | 30 | 2015 |
| Interleukin-10 and interleukin-12 modulation in patients with relapsing-remitting multiple sclerosis on therapy with interferon-beta 1a: differences in responders and non … PB Carrieri, P Ladogana, G Di Spigna, M Fulvia de Leva, M Petracca, ... Immunopharmacology and immunotoxicology 30 (4), 915-923, 2008 | 29 | 2008 |
| Imaging multiple sclerosis and other neurodegenerative diseases M Inglese, M Petracca Prion 7 (1), 47-54, 2013 | 25 | 2013 |
| Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice M De Angelis, M Petracca, R Lanzillo, VB Morra, M Moccia Multiple sclerosis and related disorders 45, 102452, 2020 | 23 | 2020 |
| Neuroimaging of multiple sclerosis, acute disseminated encephalomyelitis, and other demyelinating diseases. M Bester, M Petracca, M Inglese Seminars in roentgenology 49 (1), 76-85, 2013 | 23 | 2013 |
| MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in multiple sclerosis S Cocozza, G Pontillo, R Lanzillo, C Russo, M Petracca, M Di Stasi, ... Neuroradiology 61 (2), 155-162, 2019 | 22 | 2019 |
| Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate PB Carrieri, F Carbone, F Perna, D Bruzzese, C La Rocca, M Galgani, ... Metabolism 64 (9), 1112-1121, 2015 | 21 | 2015 |
| Synchronization and variability imbalance underlie cognitive impairment in primary-progressive multiple sclerosis M Petracca, C Saiote, HA Bender, F Arias, C Farrell, P Magioncalda, ... Scientific reports 7 (1), 1-12, 2017 | 20 | 2017 |
| Therapeutic strategies in multiple sclerosis: A focus on neuroprotection and repair and relevance to schizophrenia M Inglese, M Petracca Schizophrenia research 161 (1), 94-101, 2015 | 19 | 2015 |
| A metabolic perspective on CSF-mediated neurodegeneration in multiple sclerosis M Wentling, C Lopez-Gomez, HJ Park, M Amatruda, A Ntranos, J Aramini, ... Brain 142 (9), 2756-2774, 2019 | 18 | 2019 |
| A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis E Fox, AE Lovett-Racke, M Gormley, Y Liu, M Petracca, S Cocozza, ... Multiple Sclerosis Journal 27 (3), 420-429, 2021 | 17 | 2021 |
| Glossopharyngeal neuralgia as onset of multiple sclerosis PB Carrieri, S Montella, M Petracca The Clinical journal of pain 25 (8), 737-739, 2009 | 17 | 2009 |
| Body Mass Index in Multiple Sclerosis modulates ceramide-induced DNA methylation and disease course K Castro, A Ntranos, M Amatruda, M Petracca, P Kosa, EY Chen, ... EBioMedicine 43, 392-410, 2019 | 16 | 2019 |
Matilde IngleseGenoa, Milan, New YorkVerified email at mssm.edu
